Variant report
Variant | esv3400079 |
---|---|
Chromosome Location | chr5:29729244-29762382 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:29734347..29737280-chr5:29739042..29740849,2 | MCF-7 | breast: | |
2 | chr5:29192802..29195589-chr5:29735604..29737359,2 | K562 | blood: | |
3 | chr5:29729555..29730090-chr5:29750459..29751020,2 | MCF-7 | breast: | |
4 | chr4:181350073..181352059-chr5:29762233..29764064,2 | MCF-7 | breast: | |
5 | chr5:29729555..29730090-chr5:29750459..29751020,2 | MCF-7 | breast: | |
6 | chr5:29734347..29737280-chr5:29739042..29740849,2 | MCF-7 | breast: | |
7 | chr5:29732562..29734284-chr5:29734995..29736841,2 | K562 | blood: | |
8 | chr5:29732562..29734284-chr5:29734995..29736841,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374046973 | chr5:29744411-29744412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187492001 | chr5:29744443-29744444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144702070 | chr5:29744460-29744461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190284517 | chr5:29744488-29744489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543543489 | chr5:29744537-29744538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575655811 | chr5:29744595-29744596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs80129942 | chr5:29744613-29744614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534622058 | chr5:29744635-29744636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4391185 | chr5:29744658-29744659 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs568341592 | chr5:29744701-29744702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139871026 | chr5:29744711-29744712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557159278 | chr5:29744713-29744714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575435458 | chr5:29744736-29744737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs13156377 | chr5:29744753-29744754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75157664 | chr5:29744769-29744770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572839110 | chr5:29744772-29744773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539842648 | chr5:29744809-29744810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559644768 | chr5:29744820-29744821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577004218 | chr5:29744843-29744844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79346393 | chr5:29744845-29744846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574774835 | chr5:29744860-29744861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4523013 | chr5:29744864-29744865 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs182511925 | chr5:29744956-29744957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530913687 | chr5:29744960-29744961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552600257 | chr5:29745000-29745001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189400827 | chr5:29751407-29751408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs554909254 | chr5:29751418-29751419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560334462 | chr5:29751494-29751495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568436604 | chr5:29751540-29751541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535728267 | chr5:29751546-29751547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557541639 | chr5:29751579-29751580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568219958 | chr5:29751583-29751584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575793880 | chr5:29751591-29751592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111690422 | chr5:29751597-29751598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540001348 | chr5:29751604-29751605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537349370 | chr5:29751612-29751613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573339017 | chr5:29751621-29751622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540651156 | chr5:29751658-29751659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562014879 | chr5:29751675-29751676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182088125 | chr5:29751695-29751696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149088632 | chr5:29751717-29751718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368427593 | chr5:29751724-29751725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186743170 | chr5:29751785-29751786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191572938 | chr5:29751792-29751793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574556623 | chr5:29758655-29758656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76674626 | chr5:29758672-29758673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569948250 | chr5:29758718-29758719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540333800 | chr5:29758771-29758772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs527700141 | chr5:29758813-29758814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146972672 | chr5:29758815-29758816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29744400-29745000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr5:29751400-29751800 | Enhancers | Fetal Intestine Small | intestine |
3 | chr5:29758600-29759000 | Enhancers | HepG2 | liver |
4 | chr5:29759000-29759200 | Active TSS | Liver | Liver |
5 | chr5:29759000-29759200 | Flanking Active TSS | HepG2 | liver |
6 | chr5:29759000-29759600 | Enhancers | Fetal Intestine Large | intestine |
7 | chr5:29759000-29759600 | Active TSS | A549 | lung |
8 | chr5:29759200-29759400 | Flanking Active TSS | Liver | Liver |
9 | chr5:29759200-29759600 | Enhancers | Fetal Intestine Small | intestine |
10 | chr5:29759200-29759600 | Active TSS | HepG2 | liver |
11 | chr5:29759600-29760000 | Weak transcription | Fetal Intestine Large | intestine |
12 | chr5:29759600-29761200 | Enhancers | HepG2 | liver |
13 | chr5:29760200-29760400 | Enhancers | Fetal Intestine Large | intestine |
14 | chr5:29760200-29760400 | Enhancers | A549 | lung |
15 | chr5:29760400-29761200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |